Dailypharm Live Search Close

[Reporter¡¯s View] Accepting drugs used by very few patients

By Eo, Yun-Ho | translator Kim, Jung-Ju

23.03.29 18:13:25

°¡³ª´Ù¶ó 0



It's the same 'cancer', but different. So how should we regard these new anticancer drugs that target only a very few among all patients that have the same type of cancer?

The cancer types that we commonly refer to, such as liver cancer, stomach cancer, and lung cancer are just major categories used, and the specific condition of each patient is classified in more detail. According to the specific class of cancer, the difficulty of treatment may vary even for tumors that originate from the same organ and affect a varying number of patients.

The development of precision medicine is already heralding a shift in the prescription standards from organs to genes. In other words, the era of per

Eo, Yun-Ho(unkindfish@dailypharm.com)
If you want to see the full article, please JOIN US (click)